Immune Checkpoint Blockade in Advanced Cutaneous Squamous Cell Carcinoma: What Do We Currently Know in 2020?

Wessely, Anja; Steeb, Theresa; Leiter, Ulrike; Garbe, Claus; Berking, Carola; Heppt, Markus Vincent

dc.contributor.author	Garbe, Claus
dc.contributor.author	Leiter-Stöppke, Ulrike
dc.date.accessioned	2022-03-08T10:48:46Z
dc.date.available	2022-03-08T10:48:46Z
dc.date.issued	2020
dc.identifier.issn	1422-0067
dc.identifier.uri	http://hdl.handle.net/10900/125299
dc.language.iso	en	de_DE
dc.publisher	Mdpi	de_DE
dc.relation.uri	http://dx.doi.org/10.3390/ijms21239300	de_DE
dc.subject.ddc	540	de_DE
dc.subject.ddc	570	de_DE
dc.title	Immune Checkpoint Blockade in Advanced Cutaneous Squamous Cell Carcinoma: What Do We Currently Know in 2020?	de_DE
dc.type	Article	de_DE
utue.quellen.id	20210304112512_00431
utue.personen.roh	Wessely, Anja
utue.personen.roh	Steeb, Theresa
utue.personen.roh	Leiter, Ulrike
utue.personen.roh	Garbe, Claus
utue.personen.roh	Berking, Carola
utue.personen.roh	Heppt, Markus Vincent
dcterms.isPartOf.ZSTitelID	International Journal of Molecular Sciences	de_DE
dcterms.isPartOf.ZS-Issue	Article 9300	de_DE
dcterms.isPartOf.ZS-Volume	21 (23)	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE